Krsnaa Diagnostics Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
KRSNAA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Krsnaa Diagnostics reported standalone revenue of INR 6,909.47 million for FY2026, up 1.4% from INR 6,816.95 million in FY2025. Profit after tax grew 24% to INR 1,026.75 million from INR 828.08 million. On consolidated basis, revenue rose 7.8% to INR 7,727.74 million and PAT increased 30.7% to INR 1,014.31 million. The company issued debentures worth INR 4,173.59 million, significantly increasing non-current borrowings from INR 185.04 million to INR 4,371.44 million. Operating cash flow improved to INR 1,341.10 million from INR 893.79 million. An income tax demand of INR 626.90 million was raised against the company for multiple assessment years, which the company is contesting. The board recommended a final dividend of INR 2 per share.
Strong PAT growth above 25% is positive for shareholders, but the sharp increase in debt and ongoing tax disputes create some risk concerns. The company generated robust operating cash flows demonstrating operational strength.